▲ Peaking
Health
Tirzepatide in Adolescents With Obesity The SURMOUNT-ADOLESCENTS Randomized Clinical Trial
Tirzepatide led to substantial BMI reductions in adolescents with obesity during the phase III SURMOUNT-ADOLESCENTS trial.
1 trends tracked about this subject — the full history, oldest to newest below.
Tirzepatide led to substantial BMI reductions in adolescents with obesity during the phase III SURMOUNT-ADOLESCENTS trial.